PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsGenetic fingerprint identifies aggressive prostate cancer

BioNews

Genetic fingerprint identifies aggressive prostate cancer

Published 23 January 2017 posted in News and appears in BioNews 884

Author

Annabel Slater

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Canadian scientists have identified a genetic fingerprint that indicates which prostate cancer tumours may develop into a more aggressive form of the disease after treatment...

Canadian scientists have identified a genetic fingerprint that indicates which prostate cancer tumours may develop into a more aggressive form of the disease after treatment.

The team also found that patients with the BRCA2 gene mutation have a higher likelihood of tumour spread. These results could be used to provide more intensive treatment to patients with aggressive prostate cancer.

'This information gives us new precision about the treatment response of men with prostate cancer, and important clues as to how to better treat one set of men versus the other to improve cure rates overall,' said Professor Robert Bristow of the University of Toronto, who led the team.

Prostate cancer can be cured with radiotherapy or surgery, but up to 30 percent of men develop a more aggressive form of the disease following treatment. The researchers studied tumours from 500 Canadian men who had had localised, non-inherited prostate cancer that had been treated with surgery or radiotherapy.

'We used specialised state-of-the-art DNA sequencing techniques to focus on the genetics of prostate cancers to better understand what is so different from one man's disease to another man's disease,' said Professor Bristow.

They were able to identify a set of genetic differences between patients who are likely to respond well to surgery or radiotherapy, and in patients whose cancer is likely to spread.

A related study focused on 14 men with the BRCA2 mutation from the 500 patients, in collaboration with co-principal investigators Dr Paul Boutros of the Ontario Institute for Cancer Research and Professor Gail Risbridger of Monash University, Australia. The researchers found that the tumours of these patients contained genetic changes associated with cancer spread and resistance to hormone therapy. Just 50 percent of these patients survive five years after diagnosis, compared with a usual survival rate of 80 percent in prostate cancer patients.

'We knew that patients who had a mutation in the BRCA2 gene had increased death rates from prostate cancer but no one had studied them because they're so rare,' Dr Bristow, told Global News. Around two percent of men with prostate cancer have a BRCA2 mutation.

The researchers plan to test 500 more patients over the next two to three years.

'This is an exciting time in prostate cancer research in which the genetics of individual men and their cancers are beginning to dictate precise and customised treatment,' said Dr Bristow.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
10 May 2019 • 2 minutes read

Prostate cancer gene mutation raises risk of death by threefold

by Charlott Repschläger

A mutation that raises a prostate cancer patient's risk of death by threefold has been discovered...

PET BioNews
News
1 June 2018 • 2 minutes read

Silencing a prostate cancer gene kills tumour cells

by Dr Massimo Ganassi

A recent study identifies a new molecule as a potential target for prostate cancer therapy...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
24 October 2017 • 3 minutes read

Gene test could improve prediction of breast cancer risk

by Dr Hannah Somers

A new genetic test to accurately predict an individual's risk of developing breast cancer will soon be rolled out at two hospital clinics in Manchester...

PET BioNews
News
31 August 2017 • 2 minutes read

Liquid biopsy may help target prostate cancer treatment

by Charlotte Spicer

A new three-in-one blood test could progress personalised treatment for patients with prostate cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 November 2015 • 2 minutes read

Gene mutations can predict prostate cancer drug resistance

by Kirsty Oswald

Researchers have identified the genetic mutations that drive resistance to the hormone therapy abiraterone in patients with advanced prostate cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
11 April 2014 • 2 minutes read

Gene test can predict prostate cancer recurrence

by Simon Hazelwood-Smith

A genetic test has been developed to predict the likelihood of prostate cancer returning after treatment. The test looks for 'genetic signatures' often found in recurring cancers...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Smartphone DNA sequencer developed

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

6 July 2022 • 1 minute read

Frozen embryo transfers linked to high blood pressure in pregnancy

5 July 2022 • 1 minute read

Anorexia in pregnancy linked to increased risk of complications

5 July 2022 • 2 minutes read

Pregnancy after breast cancer treatment does not increase risk of recurrence

5 July 2022 • 1 minute read

No difference between fresh and frozen sperm for IUI

4 July 2022 • 2 minutes read

Shorter IVF protocol reduces risk of OHSS

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856